Drug Manufacturers - Other

  1. Array BioPharma Reports Positive Results (ARRY)

    Positive top-line data is paving the way for the company to apply for global regulatory ...
  2. Sarepta’s Secret Weapon: Priority Review Voucher

    Uncertainty about the extension of pediatric priority review voucher (PRV) program ...
  3. Amgen's Osteoporosis Drug Crosses a Hurdle (AMGN)

    Amgen’s osteoporosis drug moves one step ahead in the FDA approval process, and recent ...
  4. Intrexon Funds Two Startups in New Venture (XON)

    The unique model to fund budding companies working on Intrexon’s proprietary technology ...
  5. Sarepta’s Manufacturing Challenge (SRPT)

    Amid doubts about scalability of manufacturing, Sarepta has laid out plans to serve ...
  6. Can MannKind Compete Against Mylan's EpiPen? ...

    MannKind’s plan to compete against Mylan's EpiPen may dissolve as the company is ...
  1. Array BioPharma Reports Positive Results (ARRY)

    Positive top-line data is paving the way for the company to apply for global regulatory ...
  2. Sarepta’s Secret Weapon: Priority Review Voucher

    Uncertainty about the extension of pediatric priority review voucher (PRV) program ...
  3. Amgen's Osteoporosis Drug Crosses a Hurdle (AMGN)

    Amgen’s osteoporosis drug moves one step ahead in the FDA approval process, and recent ...
  4. Intrexon Funds Two Startups in New Venture (XON)

    The unique model to fund budding companies working on Intrexon’s proprietary technology ...
  5. Sarepta’s Manufacturing Challenge (SRPT)

    Amid doubts about scalability of manufacturing, Sarepta has laid out plans to serve ...
  6. Can MannKind Compete Against Mylan's EpiPen? ...

    MannKind’s plan to compete against Mylan's EpiPen may dissolve as the company is ...
  1. What factors make the drug sector good for value investing?

    Discover what makes the drugs sector good for value investing. The perfect ingredient for value investors is to find undervalued ...
  2. What annual return could an investor expect on average from the drug sector?

    Learn which annual average returns the drugs manufacturing sector and its industries can generate for investors based on ...
  3. What are the primary factors that drive share prices in the drugs sector?

    Learn about the primary factors that drive share prices in the drug sector. Creating and manufacturing drugs is a complex ...
  4. What level of return on equity is average for a company in the drugs sector?

    Find out more about the drugs sector, which industries are included in the sector and the average return on equity for companies ...
Hot Definitions
  1. North American Free Trade Agreement - NAFTA

    A regulation implemented on Jan. 1, 1994, that decreased and eventually eliminated tariffs to encourage economic activity ...
  2. Trickle-Down Theory

    An economic idea which states that decreasing marginal and capital gains tax rates - especially for corporations, investors ...
  3. Derivative

    A security with a price that is dependent upon or derived from one or more underlying assets.
  4. Fiduciary

    A fiduciary is a person who acts on behalf of another person, or persons to manage assets.
  5. Sharpe Ratio

    The Sharpe Ratio is a measure for calculating risk-adjusted return, and this ratio has become the industry standard for such ...
  6. Death Taxes

    Taxes imposed by the federal and/or state government on someone's estate upon their death. These taxes are levied on the ...
Trading Center